GAVISCON

Main information

  • Trade name:
  • GAVISCON chewable tablet
  • Pharmaceutical form:
  • chewable tablet
  • Prescription type:
  • No Prescription (OTC)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • GAVISCON chewable tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Alginic acid
  • Product summary:
  • Suitability for use in older adult patients Acidum alginicum Suitable for older persons. Natrii hydrogenocarbonas Suitable for older persons. Aluminii hydroxidum gel. siccatum Avoid use in older persons. Inappropriate as a laxative for older persons. Avoid use in even mild renal insufficiency. May cause adverse neurological effects. Take interactions in the absorption phase into account.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 9265
  • Authorization date:
  • 17-10-2008
  • Last update:
  • 26-07-2018